Therapeutic Variables in Cataract Surgery

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare patient outcomes in following cataract surgery in patients randomized to one of two surgical kits.

• Phase: Phase 4

Details

• Lead Sponsor: Innovative Medical
• Treatments: Gatifloxacin; Ketorolac; Methylprednisolone; Methylprednisolone acetate; Methylprednisolone Hemisuccinate; Moxifloxacin; Nepafenac; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate

Criteria

Inclusion Criteria:

• Males or females scheduled to undergo cataract surgery

• Patients can be receiving monofocal IOLs only

• Likely to complete all study visits and able to provide informed consent

• Visual potential of 20/25 or better

Exclusion Criteria:

• Known contraindications to any study medication or ingredients

• Active ocular diseases or uncontrolled systemic disease

• Active ocular allergies